SANUWAVE Will Host a Conference Call on March 22, 2024 at 8:30 AM (ET) to Present the Q4 and FY2023 Financial Results
20 mars 2024 07h00 HE
|
SANUWAVE Health, Inc.
EDEN PRAIRIE, MN, March 20, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – SANUWAVE Health, Inc. (the "Company" or "Sanuwave”) (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound...
Biora Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update
18 mars 2024 08h00 HE
|
Biora Therapeutics, Inc.
Biora's management will host a webcast and conference call on Tuesday, March 26, 2024, after the close of financial markets.
Niu Technologies Announces Unaudited Fourth Quarter and Full Year 2023 Financial Results
18 mars 2024 03h00 HE
|
NIU Technologies
-- Fourth Quarter Revenues of RMB 478.7 million, down 21.8% year over year -- Fourth Quarter Net Loss of RMB 130.2 million, compared to net loss of RMB 37.1 million in the same period of last year ...
Profire Energy Reports Financial Results for Fourth Quarter and Full Fiscal Year 2023
13 mars 2024 16h30 HE
|
Profire Energy, Inc.
LINDON, Utah, March 13, 2024 (GLOBE NEWSWIRE) -- Profire Energy, Inc. (NASDAQ: PFIE), a technology company (the "Company") that provides solutions which enhance the efficiency, safety, and...
SuRo Capital Corp. Reports Fourth Quarter and Fiscal Year 2023 Financial Results
13 mars 2024 16h05 HE
|
SuRo Capital Corp.
Net Asset Value of $7.99 Per Share as of December 31, 2023 Modified Dutch Auction Tender Offer to Repurchase Up To 2 Million Shares Commenced on February 20 ...
Acorn’s 2023 EPS Improves to $0.05 vs. ($0.25) Loss Per Share on 15% Revenue Increase; Anticipates Continued Revenue and Earnings Growth in 2024
07 mars 2024 07h59 HE
|
Acorn Energy, Inc.
Acorn’s 2023 EPS Improves to $0.05 vs. ($0.25) Loss Per Share on 15% Revenue Increase; Anticipates Continued Revenue & Earnings Growth in 2024. Call today.
SuRo Capital Corp. to Report Fourth Quarter and Fiscal Year 2023 Financial Results on Wednesday, March 13, 2024
06 mars 2024 16h05 HE
|
SuRo Capital Corp.
NEW YORK, March 06, 2024 (GLOBE NEWSWIRE) -- SuRo Capital Corp. (“SuRo Capital”) (Nasdaq: SSSS) today announced that it will report its financial results for the quarter and fiscal year ended...
CompoSecure Reports Fourth Quarter and Full Year 2023 Financial Results
06 mars 2024 16h01 HE
|
CompoSecure, Inc.
Q4 Net Sales up 7% to $100 Million; Q4 Net Income up 39% to $31 Million; Q4 Adj. EBITDA up 22% to $37 Million Issues 2024 Guidance of Net Sales Between $408-$428 Million; Adj. EBITDA Between...
Broadwind Announces Fourth Quarter and Full-Year 2023 Results
05 mars 2024 07h00 HE
|
Broadwind, Inc.
CICERO, Ill., March 05, 2024 (GLOBE NEWSWIRE) -- Broadwind (Nasdaq: BWEN, or the “Company”), a diversified precision manufacturer of specialized components and solutions serving global markets,...
Arbutus Reports Fourth Quarter and Year End 2023 Financial Results and Provides Corporate Update
29 févr. 2024 07h30 HE
|
Arbutus Biopharma Corporation
On-track to report key clinical data in 2024 from two on-going Phase 2a clinical trials with imdusiran and the Phase 1a/1b clinical trial with AB-101 Plans to initiate a third Phase 2a clinical...